Day: December 9, 2022

AS Tallinna Sadam subsidiary OÜ TS Shipping (hereinafter: “TS Shipping”) and Baffinland Iron Mines Corporation (hereinafter: “Baffinland”) extended the 5-year framework agreement of chartering the icebreaker Botnica signed in 2018 for the summer period of 2023. Baffinland has a call option to continue chartering Botnica under the same conditions from the end of June to the end of November. More detailed decisions regarding charter period will be made by Baffinland by the call option notification due date in February 2023. In the beginning of summer 2018, TS Shipping, signed an agreement with Baffinland for chartering MPSV Botnica for the 2018 summer period and annual call options for the summer periods in 2019-2022 Baffinland is a Canadian mining company, engaged in the mining of iron ore on Baffin Island in Northern...

TAINAN, Taiwan, Dec. 09, 2022 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced its WiseEye™ Always-On smart image sensing total solution (“WiseEye”) received the award for “Most Promising Product” at the EE Awards Asia 2022 hosted by EE Times and EDN Asia on December 8, 2022. Himax’s WiseEye incorporates a proprietary ultralow power WE1 Plus AI processor, Always-On CMOS image sensor (“AOS”), and CNN-based AI algorithm, featuring tinyML AI in tiny form factor, ultralow power consumption, low latency, privacy protection and optimized cost. WiseEye is the industry leader in requiring only a few milliwatts (mW) for computer vision deployment on battery-powered endpoint applications....

AS Nordecon group company Tariston AS and OÜ Rail Baltic Estonia signed a contract for the construction of the Tagadi ecoduct on the Rail Baltica route in Harju county. The cost of the contract is 5.3 million euros plus value added tax. The works will be completed in September 2024. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Finland, Ukraine and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. The consolidated revenue of the Group in 2021 was 289 million euros. Currently Nordecon Group employs close to 670 people. Since 18 May 2006 the company’s shares have been quoted in the main list of...

A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication and research into myeloid neoplasms Four scientific posters featuring results from OGM applications in myeloid cancers, acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS) and hematological malignancy research, including one poster covering a multi-site study in Spain on data analysis for OGM for leukemia and lymphoma research, will be presented at the conferenceSAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American Society of Hematology (ASH) Annual Meeting and Exposition 2022 with a broad range of content covering optical genome mapping’s...

SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, today announced the pricing of an underwritten offering of 4,545,455 shares of its common stock at a price to the public of $110 per share. All of the shares to be sold in the offering are to be sold by Prometheus. The gross proceeds to Prometheus from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $500 million. The offering is expected to close on or about December 13, 2022, subject to the satisfaction of customary closing conditions....

Myriad’s MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries SALT LAKE CITY, Dec. 08, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more accurate predictor of breast cancer risk than a standard-of-care risk assessment alone. The data was shared in a spotlight discussion at the 2022 San Antonio Breast Cancer Symposium. Working with industry-leading researchers, Myriad Genetics studied outcomes from more than 130,000 women who received RiskScore results. By analyzing data on whether women developed breast cancer after their initial test result, the study demonstrated that RiskScore was...